BioSyent (RX) Insider Trading & Ownership C$11.06 +0.05 (+0.45%) (As of 11/15/2024 05:32 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider Trades BioSyent (CVE:RX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.65%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$52,327.95Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)C$5.11 M Get RX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioSyent stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RX Insider Buying and Selling by Quarter Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! BioSyent Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/23/2024Peter Douglas LockhardDirectorSell600C$11.10C$6,660.009/20/2024Seyed Ahmad AshrafiDirectorSell2,320C$10.95C$25,404.007/23/2024FAX Capital Corp.InsiderSell500,000C$10.05C$5,025,000.006/28/2024Sharan RaghubirSenior OfficerSell423C$10.04C$4,246.926/20/2024Sharan RaghubirSenior OfficerSell1,755C$10.01C$17,566.506/12/2024Rene GoehrumDirectorSell1,522C$9.38C$14,276.36 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/22/2024Peter Douglas LockhardDirectorSell432C$8.95C$3,866.404/29/2024BioSyent Inc.InsiderBuy5,100C$8.55C$43,627.953/28/2024Larry AndrewsDirectorBuy1,000C$8.70C$8,700.003/26/2024Peter Douglas LockhardDirectorSell600C$8.70C$5,220.0011/27/2023Seyed Ahmad AshrafiDirectorSell1,000C$8.50C$8,500.00 (Data available from 1/1/2013 forward) RX Insider Trading Activity - Frequently Asked Questions Who is on BioSyent's Insider Roster? The list of insiders at BioSyent includes BioSyent Inc., Blair Driscoll, FAX Capital Corp., Larry Andrews, Peter Douglas Lockhard, Rene Goehrum, Seyed Ahmad Ashrafi, and Sharan Raghubir. Learn more on insiders at RX. What percentage of BioSyent stock is owned by insiders? 33.65% of BioSyent stock is owned by insiders. Learn more on RX's insider holdings. Which BioSyent insiders have been buying company stock? The following insiders have purchased RX shares in the last 24 months: BioSyent Inc. (C$43,627.95), and Larry Andrews (C$8,700.00). How much insider buying is happening at BioSyent? Insiders have purchased a total of 6,100 RX shares in the last 24 months for a total of C$52,327.95 bought. Which BioSyent insiders have been selling company stock? The following insiders have sold RX shares in the last 24 months: FAX Capital Corp. (C$5,025,000.00), Peter Douglas Lockhard (C$15,746.40), Rene Goehrum (C$14,276.36), Seyed Ahmad Ashrafi (C$33,904.00), and Sharan Raghubir (C$21,813.42). How much insider selling is happening at BioSyent? Insiders have sold a total of 508,652 BioSyent shares in the last 24 months for a total of C$5,110,740.18 sold. BioSyent Key ExecutivesMr. René C. Goehrum (Age 65)Chairman, CEO & President Compensation: $594.99k1 recent tradesMr. Robert J. MarchVP of Finance & CFOMr. Joost van der MarkVice President of Corporate DevelopmentMs. Neelu AtwalDirector of Human Resources More Insider Trading Tools from MarketBeat Related Companies Canopy Growth Insider Trades Aurora Cannabis Insider Trades Organigram Insider Trades HLS Therapeutics Insider Trades SugarBud Craft Growers Insider Trades Medexus Pharmaceuticals Insider Trades Decibel Cannabis Insider Trades Willow Biosciences Insider Trades Indiva Insider Trades Entourage Health Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (CVE:RX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSyent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.